Search

everythinglearnresearchcommunity

for

Search:↓

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Magnetic nanovesicles from stem cells can improve hair growth by staying in the skin longer.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

Sweat gland development involves two unique skin cell programs and a temporary skin environment.

ADAM 10 and ADAM 12 proteins are involved in different stages of hair growth and could be targets for treating hair disorders.

Mesotherapy might be a useful addition to dental surgery to reduce drug use and side effects, but more research is needed.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Exosomes could be effective for improving skin health and treating skin diseases.

Hydroxychloroquine may help delay skin damage in lupus patients.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Physical activity, height, and smoking affect prostate cancer risk.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.